Science 37 Holdings Management
Management criteria checks 2/4
Science 37 Holdings' CEO is Dave Coman, appointed in Nov 2019, has a tenure of 4.33 years. total yearly compensation is $8.06M, comprised of 6.8% salary and 93.2% bonuses, including company stock and options. directly owns 0.89% of the company’s shares, worth $309.55K. The average tenure of the management team and the board of directors is 3.3 years and 2.4 years respectively.
Key information
Dave Coman
Chief executive officer
US$8.1m
Total compensation
CEO salary percentage | 6.8% |
CEO tenure | 4.3yrs |
CEO ownership | 0.9% |
Management average tenure | 3.3yrs |
Board average tenure | 2.4yrs |
Recent management updates
Recent updates
Science 37 Holdings, Inc. (NASDAQ:SNCE) Might Not Be As Mispriced As It Looks
Dec 18Investors Continue Waiting On Sidelines For Science 37 Holdings, Inc. (NASDAQ:SNCE)
Apr 17Science 37, Syapse team for faster patient enrollment in cancer trials
Aug 18Science 37 reports Q2 mixed earnings; narrows FY22 guidance
Aug 11Results: Science 37 Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
May 13Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans
Apr 11Science 37: Pioneering Decentralized Clinical Trials
Jan 02We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth
Nov 04CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -US$125m |
Jun 30 2023 | n/a | n/a | -US$134m |
Mar 31 2023 | n/a | n/a | -US$121m |
Dec 31 2022 | US$8m | US$550k | -US$51m |
Sep 30 2022 | n/a | n/a | -US$50m |
Jun 30 2022 | n/a | n/a | -US$41m |
Mar 31 2022 | n/a | n/a | -US$43m |
Dec 31 2021 | US$8m | US$435k | -US$94m |
Sep 30 2021 | n/a | n/a | -US$42m |
Jun 30 2021 | n/a | n/a | -US$35m |
Mar 31 2021 | n/a | n/a | -US$33m |
Dec 31 2020 | US$1m | US$400k | -US$32m |
Compensation vs Market: Dave's total compensation ($USD8.06M) is above average for companies of similar size in the US market ($USD662.89K).
Compensation vs Earnings: Dave's compensation has been consistent with company performance over the past year.
CEO
Dave Coman (53 yo)
4.3yrs
Tenure
US$8,062,854
Compensation
Mr. David Coman, also known as Dave, has been Chief Executive Officer of Science 37 Holdings, Inc. (formerly known as Science 37, Inc.) since November 2019 and serves as its Director since October 2021. He...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 4.3yrs | US$8.06m | 0.89% $ 309.5k | |
Chief Legal & Human Resources Officer and Secretary | 2.7yrs | US$4.65m | 0.24% $ 83.4k | |
Chief Delivery Officer | 4.2yrs | US$3.93m | 0.26% $ 90.6k | |
Chief Financial Officer | 3.9yrs | no data | 0.15% $ 52.2k | |
VP and Head of Quality Assurance & Compliance | less than a year | no data | no data | |
Vice President of Marketing & Communications | 3.8yrs | no data | no data | |
Chief Strategy & Marketing Officer | no data | no data | no data | |
Chief Medical Officer | 4.8yrs | US$486.60k | 0.69% $ 240.9k | |
Chief Commercial Officer | 1.5yrs | no data | 0.059% $ 20.4k | |
VP of Corporate Strategy & Chief of Staff | 2.2yrs | no data | no data | |
Senior VP of Patient & Provider Networks | less than a year | no data | no data |
3.3yrs
Average Tenure
51.5yo
Average Age
Experienced Management: SNCE's management team is considered experienced (3.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 2.4yrs | US$8.06m | 0.89% $ 309.5k | |
Independent Director | 3.5yrs | US$180.00k | 0.034% $ 11.8k | |
Independent Chairman of the Board | 2.4yrs | US$215.00k | 0.034% $ 11.8k | |
Independent Director | 1.5yrs | US$93.33k | 0.038% $ 13.2k | |
Independent Director | 2.4yrs | no data | no data | |
Independent Director | 2.4yrs | US$165.00k | 0.034% $ 11.8k | |
Independent Director | 2.4yrs | US$185.00k | 0.034% $ 11.8k |
2.4yrs
Average Tenure
53yo
Average Age
Experienced Board: SNCE's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.